Penumbra
PEN
$189.47
Share price
0.78%
Change (1 day)
-39.71%
Change (1 year)
Categories
Penumbra, Inc., is an American company that develops, manufactures and sells medical devices for neurovascular and vascular medicine applications.
P/S ratio for Penumbra (PEN)
P/S ratio as of June 2024 (TTM): 6.77
According to Penumbra's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 6.76895. At the end of 2023 the company had a P/S ratio of 9.17.
P/S ratio history for Penumbra from 2015 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 9.17 | -8.04% |
| 2022 | 9.97 | -30.54% |
| 2021 | 14.4 | 26.63% |
| 2020 | 11.3 | 7.95% |
| 2019 | 10.5 | 11.05% |
| 2018 | 9.46 | -1.15% |
| 2017 | 9.57 | 24.8% |
| 2016 | 7.67 | -11.31% |
| 2015 | 8.65 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Merit Medical MMSI | 3.66 | -45.88% | 🇺🇸 USA |
 Inari Medical
NARI | 5.66 | -16.38% | 🇺🇸 USA |